Publicacións (62) Publicacións de Maximino Abraldes Lopez-Veiga

2024

  1. Burden of Disease Study of Patients with Diabetic Macular Oedema in Spain

    Ophthalmology and Therapy, Vol. 13, Núm. 7, pp. 1937-1953

  2. Burden of Disease Study of Patients with Neovascular Age-Related Macular Degeneration in Spain

    Ophthalmology and Therapy, Vol. 13, Núm. 7, pp. 1925-1935

  3. Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration

    Ophthalmology Retina, Vol. 8, Núm. 4, pp. 350-359

  4. Relationships between Patient-Reported Outcome Measures and Clinical Measures in Naïve Neovascular Age-Related Macular Degeneration Patients Treated with Intravitreal Ranibizumab

    Pharmaceuticals, Vol. 17, Núm. 2

  5. The Effect of Systemic Parameters and Baseline Characteristics in Short-Term Response Analysis with Intravitreal Ranibizumab in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration

    Pharmaceutics, Vol. 16, Núm. 1

2023

  1. Análisis coste-utilidad del modelo de unidad de terapia intravítrea (UTI) frente a la administración tradicional de terapia intravítrea

    Archivos de la Sociedad Española de Oftalmologia, Vol. 98, Núm. 11, pp. 619-626

  2. Artificial intelligence-based fluid quantification and associated visual outcomes in a real-world, multicentre neovascular age-related macular degeneration national database

    British Journal of Ophthalmology, Vol. 108, Núm. 2, pp. 253-262

  3. Influence of Genetic Polymorphisms on the Short-Term Response to Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration

    Investigative ophthalmology & visual science, Vol. 64, Núm. 13, pp. 34

2022

  1. CHARACTERIZING COVID-19-RELATED RETINAL VASCULAR OCCLUSIONS: A Case Series and Review of the Literature

    Retina (Philadelphia, Pa.), Vol. 42, Núm. 3, pp. 465-475

  2. Improvement of Retinal Images Affected by Cataracts

    Photonics, Vol. 9, Núm. 4

2021

  1. A randomized study of nutritional supplementation in patients with unilateral wet age-related macular degeneration

    Nutrients, Vol. 13, Núm. 4

  2. Economic burden of age-related macular degeneration in routine clinical practice: the RAMDEBURS study

    International Ophthalmology, Vol. 41, Núm. 10, pp. 3427-3436

  3. Prevalence of age-related macular degeneration among optometric telemedicine users in Spain: a retrospective nationwide population-based study

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 259, Núm. 7, pp. 1993-2003

  4. Remote screening of retinal and optic disc diseases using handheld nonmydriatic cameras in programmed routine occupational health checkups onsite at work centers

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 259, Núm. 3, pp. 575-583

2020

  1. Anti-VEGF treatment and response in age-related macular degeneration: Disease’s susceptibility, pharmacogenetics and pharmacokinetics

    Current Medicinal Chemistry, Vol. 27, Núm. 4, pp. 549-569

  2. Características clínicas, manejo y resultados de los pacientes con endoftalmitis estéril asociados con la inyección intravítrea de factores de crecimiento endotelial antivascular

    Archivos de la Sociedad Española de Oftalmologia, Vol. 95, Núm. 5, pp. 211-216

  3. Clinical-decision criteria to identify recurrent diabetic macular edema patients suitable for fluocinolone acetonide implant therapy (Iluvien®) and follow-up considerations/ recommendations

    Clinical Ophthalmology, Vol. 14, pp. 2091-2107

  4. Pharmacological advances in the treatment of age-related macular degeneration

    Current Medicinal Chemistry, Vol. 27, Núm. 4, pp. 583-598

2019

  1. A novel automatic method to estimate visual acuity and analyze the retinal vasculature in retinal vein occlusion using swept source optical coherence tomography angiography

    Journal of Clinical Medicine, Vol. 8, Núm. 10

  2. Age and gender influence on foveal avascular zone in healthy eyes

    Experimental Eye Research, Vol. 189